Marina Shargorodska Burkhart

Marina Shargorodska Burkhart has a diverse work experience spanning from 2003 to the present. Marina currently owns their own business, MSB Advisory, which they started in 2021. Prior to that, Marina held various roles including being an Advisory Board Member at OMFIF since 2010 and co-founding Daolab in 2018. Marina also served as the Head of Investor Relations at Forty51 Ventures from 2021 to 2022 and worked as a Communications Advisor at Molecular Partners AG in 2019. Additionally, Marina has experience in capital formation at Nextech Invest from 2014 to 2018 and as the Head of Business Development at Quantum Global Investment Management from 2010 to 2015. Marina has also worked as an Independent Consultant at Miro China in 2008 and held the role of President of Global Development at Intelligent Medical Diagnostics from 2004 to 2007. Marina began their career as an Oncology Nurse Specialist at ST. ELIZABETH'S MEDICAL CENTERS from 2003 to 2005.

Marina Shargorodska Burkhart completed their Bachelor's degree in Science from UMass Boston, where they studied from 1999 to 2003. Later, they pursued an MBA in Business Administration at USP - Universidade de São Paulo from 2009 to 2010.